Interstitial Lung Diseases

This page lists the latest material on Interstitial Lung Diseases.

Severe emphysema and not progressive fibrosis, as the long-term sequela of hypersensitivity pneumonitis caused by a contaminated humidifier G. Walters (Birmingham Heartlands Hospital, United Kingdom), A. Robertson (Birmingham Heartlands Hospital, United Kingdom), S. Burge (Birmingham Heartlands Hospital, United Kingdom)
YKL-40 and KL-6 in serum and sputum samples of patients diagnosed with hypersensitivity pneumonitis. S. Sánchez-Díez (Barcelona, Spain), M. Cruz (Barcelona, Spain), M. De Homdedeu (Barcelona, Spain), I. Ojanguren (Barcelona, Spain), C. Romero-Mesones (Barcelona, Spain), A. Villar (Barcelona, Spain), X. Muñoz (Barcelona, Spain)
Multidisciplinary diagnosis of interstitial lung disease: a retrospective analysis A. Magalhães (Lisboa, Portugal), I. Moreira (Lisboa, Portugal), A. Borba (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal)
Does Endobronchial Ultrasound-guided transbronchial needle aspiration (EBUS) alter the diagnosis in suspected Sarcoidosis? R. Salman (Leeds, United Kingdom), T. Sutherland (Leeds, United Kingdom)
Sinonasal sarcoidosis in Iran A. Abedini (Tehran, Islamic Republic of Iran), A. Kiani (Tehran, Islamic Republic of Iran), A. Safavi Naeini (Tehran, Islamic Republic of Iran), K. Taghavi (Tehran, Islamic Republic of Iran), N. Bandegani (Tehran, Islamic Republic of Iran), M. Kazempour-Dizaji (Tehran, Islamic Republic of Iran)
Close correlation between cumulative corticosteroid dose and weight gain in a German cohort of sarcoid patients. L. Kenn (Nürnberg, Germany), R. Apel (Hnn, Germany), B. Jaeger (Hannover, Germany), A. Prasse (Hannover, Germany)
CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria K. Katayama (Osaka, Japan), T. Arai (Osaka, Japan), K. Tachibana (Osaka, Japan), N. Takeuchi (Osaka, Japan), C. Sugimoto (Osaka, Japan), M. Akira (Osaka, Japan), T. Kasai (Osaka, Japan), M. Kitaichi (Wakayama, Japan), S. Hayashi (Osaka, Japan), Y. Inoue (Osaka, Japan)
Characterization of the lymphocyte phenotype in bronchoalveolar lavage as a prognostic marker in pulmonary sarcoidosis P. Segovia Calero (Girona, Spain), M. Ramón Belmonte (Barcelona, Spain), M. Culebras Amigo (Barcelona, Spain), I. Ojanguren Arranz (Barcelona, Spain), A. Villar Gómez (Barcelona, Spain)
Lung involvement in autoimmune liver diseases M. Brovko (Moscow, Russian Federation), M. Kalashnikov (Moscow, Russian Federation), L. Akulkina (Moscow, Russian Federation), V. Sholomova (Moscow, Russian Federation), A. Yanakaewa (Moscow, Russian Federation), D. Konovalov (Moscow, Russian Federation), M. Lebedeva (Moscow, Russian Federation), T. Rosina (Moscow, Russian Federation), S. Moiseev (Moscow, Russian Federation)
Peptide ToAP3 from T. obscurus interferes with idiopathic pulmonary fibrosis progression in murine model. K. Smidt Simon (Brasília, Brazil), C. Melo-Silva (Brasília, Brazil), P. Veloso (Brasília, Brazil), L. Coelho (Brasília, Brazil), J. Longo (Brasília, Brazil), L. Vianna (Brasília, Brazil), V. Amado (Brasília, Brazil), A. Bocca (Brasília, Brazil)
Interstitial pneumonia with autoimmune features associated with myositis autoantibodies: clinical characteristics from a multicenter Latin-American cohort. J. Juárez León (Ciudad de México, Mexico), M. Alberti (Buenos Aires, Argentina), V. Wolff (Santiago de Chile, Chile), F. Reyes (Santiago de Chile, Chile), F. Paulin (Buenos Aires, Argentina), L. Fassola (Buenos Aires, Argentina), F. Caro (Buenos Aires, Argentina), G. Carballo (Buenos Aires, Argentina), T. Palavecino (Santiago de Chile, Chile), J. Díaz (Santiago de Chile, Chile), I. Buendía Roldán (Ciudad de México, Mexico), M. Mejía (Ciudad de México, Mexico), M. Florenzano (Santiago de Chile, Chile), J. Rojas Serrano (Ciudad de México, Mexico)
Imaging of interstitial lung diseases S. Piciucchi (Forlì, Italy)
“Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis.” Bridget F. Collins and Ganesh Raghu. Eur Respir Rev 2019; 28: 190022. Eur Respir Rev, 28 (154) 195022; 10.1183/16000617.5022-2019
Paediatric ILDs Andrew Bush (London, United Kingdom)
The future of ILD: “smarter splitting and smarter lumping” Athol Wells (London, United Kingdom)
Sarcoidosis Marlies S. Wijsenbeek (Rotterdam, Netherlands)
Pathology of ILDs Venerino Poletti (Forlì, Italy)
Clinical diagnosis, monitoring and biomarkers in ILDs Michael Kreuter (Heidelberg, Germany)
“The therapy of idiopathic pulmonary fibrosis: what is next?” Vivien Somogyi, Nazia Chaudhuri, Sebastiano Emanuele Torrisi, et al. Eur Respir Rev 2019; 28: 190021. Eur Respir Rev, 28 (153) 195021; 10.1183/16000617.5021-2019
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases Vincent Cottin Eur Respir Rev, 28 (153) 190109; 10.1183/16000617.0109-2019
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases Lutz Wollin, Jörg H.W. Distler, Elizabeth F. Redente, David W.H. Riches, Susanne Stowasser, Rozsa Schlenker-Herceg, Toby M. Maher, Martin Kolb Eur Respir J, 54 (3) 1900161; 10.1183/13993003.00161-2019
King's Brief Interstitial Lung Disease questionnaire: responsiveness and minimum clinically important difference Claire M. Nolan, Surinder S. Birring, Matthew Maddocks, Toby M. Maher, Suhani Patel, Ruth E. Barker, Sarah E. Jones, Jessica A. Walsh, Stephanie C. Wynne, Peter M. George, William D-C. Man Eur Respir J, 54 (3) 1900281; 10.1183/13993003.00281-2019
Radiomic measures from chest high-resolution computed tomography associated with lung function in sarcoidosis Sarah M. Ryan, Tasha E. Fingerlin, Margaret Mroz, Briana Barkes, Nabeel Hamzeh, Lisa A. Maier, Nichole E. Carlson Eur Respir J, 54 (2) 1900371; 10.1183/13993003.00371-2019
Are estimations of radiomic image markers dispensable due to recent deep learning findings? Martin Obert Eur Respir J, 54 (2) 1901185; 10.1183/13993003.01185-2019
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis Christina Morse, Tracy Tabib, John Sembrat, Kristina L. Buschur, Humberto Trejo Bittar, Eleanor Valenzi, Yale Jiang, Daniel J. Kass, Kevin Gibson, Wei Chen, Ana Mora, Panayiotis V. Benos, Mauricio Rojas, Robert Lafyatis Eur Respir J, 54 (2) 1802441; 10.1183/13993003.02441-2018
Dysregulated balance of lung macrophage populations in idiopathic pulmonary fibrosis revealed by single-cell RNA seq: an unstable “ménage-à-trois” Bernard Mari, Bruno Crestani Eur Respir J, 54 (2) 1901229; 10.1183/13993003.01229-2019
The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement P. D. Blanc, I. Annesi-Maesano, J. R. Balmes, et al. Am J Respir Crit Care Med 2019; 199: 1312-1334
How to diagnose ILD V. Cottin (Lyon, France), M. Kreuter (Heidelberg, Germany)
Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease Joseph Jacob, Catherine M. Owens, Alan S. Brody, Thomas Semple, Tom A. Watson, Alistair Calder, Pilar Garcia-Peña, Paolo Toma, Anand Devaraj, Henry Walton, Antonio Moreno-Galdó, Paul Aurora, Alexandra Rice, Timothy J. Vece, Steve Cunningham, Andre Altmann, Athol U. Wells, Andrew G. Nicholson, Andrew Bush ERJ Open Res, 5 (3) 00100-2019; 10.1183/23120541.00100-2019
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis Joseph Barnett, Philip L. Molyneaux, Bhavin Rawal, Rezaur Abdullah, Samanjit S. Hare, Rama Vancheeswaran, Sujal R. Desai, Toby M. Maher, Athol U. Wells, Anand Devaraj Eur Respir J, 54 (1) 1900531; 10.1183/13993003.00531-2019
Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey Simon L.F. Walsh, Luca Richeldi Eur Respir J, 54 (1) 1900906; 10.1183/13993003.00906-2019
Bi-allelic missense ABCA3 mutations in a patient with childhood ILD who reached adulthood Effrosyni D. Manali, Marie Legendre, Nadia Nathan, Caroline Kannengiesser, Aurore Coulomb-L'Hermine, Theofanis Tsiligiannis, Pericles Tomos, Matthias Griese, Raphael Borie, Annick Clement, Serge Amselem, Bruno Crestani, Spyros A. Papiris ERJ Open Res, 5 (3) 00066-2019; 10.1183/23120541.00066-2019
An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13 Eid A. Al-Mutairy, Faiga Ahmad Imtiaz, Mohammed Khalid, Somaya Al Qattan, Soad Saleh, Linah Mahmood Mahmoud, Maher Mohammed Al-Saif, Latifa Al-Haj, Azizah Al-Enazi, Abdullah M. AlJebreen, Shamayel Faheem Mohammed, Abdullah Fahad Mobeireek, Khalid Alkattan, Muzamil Amin Chisti, Irina G. Luzina, Mohammed Al-Owain, Ihab Weheba, Abeer Mohamed Abdelsayed, Khushnooda Ramzan, Luke J. Janssen, Walter Conca, Ayodele Alaiya, Kate S. Collison, Brian F. Meyer, Sergei P. Atamas, Khalid S. Khabar, Jeffrey D. Hasday, Futwan Al-Mohanna Eur Respir J, 54 (1) 1802041; 10.1183/13993003.02041-2018
Prolidase deficiency diagnosed by whole exome sequencing in a child with pulmonary capillaritis Jonathan H. Rayment, Rebekah Jobling, Sarah Bowdin, Ernest Cutz, Sharon D. Dell ERJ Open Res, 5 (2) 00205-2018; 10.1183/23120541.00205-2018
Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing Jose M. Lorenzo-Salazar, Shwu-Fan Ma, Jonathan Jou, Pei-Chi Hou, Beatriz Guillen-Guio, Richard J. Allen, R. Gisli Jenkins, Louise V. Wain, Justin M. Oldham, Imre Noth, Carlos Flores ERJ Open Res, 5 (2) 00071-2019; 10.1183/23120541.00071-2019
Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage Christopher J. Ryerson, Martin Kolb, Luca Richeldi, Joyce Lee, Daniel Wachtlin, Susanne Stowasser, Venerino Poletti ERJ Open Res, 5 (2) 00127-2018; 10.1183/23120541.00127-2018
Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry Jaana Kaunisto, Eija-Riitta Salomaa, Ulla Hodgson, Riitta Kaarteenaho, Hannu Kankaanranta, Katri Koli, Tero Vahlberg, Marjukka Myllärniemi ERJ Open Res, 5 (3) 00170-2018; 10.1183/23120541.00170-2018
Clarifying the diagnosis of post-inflammatory pulmonary fibrosis: a population-based study Ann Vu, Amit Vasireddy, Teng Moua, Misbah Baqir, Jay H. Ryu Eur Respir J, 54 (1) 1900103; 10.1183/13993003.00103-2019
Diffuse parenchymal lung diseases Ulrich Costabel (Germany)
Communication difficulties reported by patients diagnosed with idiopathic pulmonary fibrosis and their carers: a European focus group study Sarah Masefield, Nicola Cassidy, Derek Ross, Pippa Powell, Athol Wells ERJ Open Res, 5 (2) 00055-2019; 10.1183/23120541.00055-2019
IPF - Idiopathic Pulmonary Fibrosis Breathe, 15 (2) 153; 10.1183/20734735.ELF152
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Guillermo Suarez-Cuartin, Maria Molina-Molina Breathe, 15 (2) 144; 10.1183/20734735.0016-2019
Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial Andrew W. Creamer, Shaney L. Barratt Breathe, 15 (2) 140; 10.1183/20734735.0002-2019
Is it safe to prescribe benzodiazepines or opioids for dyspnoea in interstitial lung disease? Lydia J. Finney Breathe, 15 (2) 137; 10.1183/20734735.0015-2019
In patients with idiopathic pulmonary fibrosis the presence of hiatus hernia is associated with disease progression and mortality John A. Mackintosh, Sujal R. Desai, Huzaifa Adamali, Kinesh Patel, Felix Chua, Anand Devaraj, Vasilis Kouranos, Maria Kokosi, George Margaritopoulos, Elisabetta A. Renzoni, Athol U. Wells, Philip L. Molyneaux, Sacheen Kumar, Toby M. Maher, Peter M. George Eur Respir J, 53 (5) 1802412; 10.1183/13993003.02412-2018
The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis Vincent Cottin, Isabella Annesi-Maesano, Andreas Günther, Liam Galvin, Michael Kreuter, Pippa Powell, Antje Prasse, George Reynolds, Luca Richeldi, Paolo Spagnolo, Claudia Valenzuela, Marlies Wijsenbeek, Wim A. Wuyts, Bruno Crestani Eur Respir J, 53 (5) 1900539; 10.1183/13993003.00539-2019
Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion Tomoyuki Fujisawa, Kazutaka Mori, Masashi Mikamo, Takashi Ohno, Kensuke Kataoka, Chikatoshi Sugimoto, Hideya Kitamura, Noriyuki Enomoto, Ryoko Egashira, Hiromitsu Sumikawa, Tae Iwasawa, Shoichiro Matsushita, Hiroaki Sugiura, Mikiko Hashisako, Tomonori Tanaka, Yasuhiro Terasaki, Shinobu Kunugi, Masashi Kitani, Ryo Okuda, Yasuoki Horiike, Yasunori Enomoto, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Yutaro Nakamura, Junya Fukuoka, Takeshi Johkoh, Yasuhiro Kondoh, Takashi Ogura, Yoshikazu Inoue, Yoshinori Hasegawa, Naohiko Inase, Sakae Homma, Takafumi Suda Eur Respir J, 53 (5) 1802243; 10.1183/13993003.02243-2018
Practical eminence and experience-based recommendations for treatment of sarcoidosis M. Drent (Ede, The Netherlands), U. Costabel (Essen, Germany)
ILD and autoimmunity - How to make your diagnosis and manage your patients V. Poletti (Forli, Italy), V. Cottin (Lyon, France)
From the pathophysiology of the human lung alveolus to epigenetic editing: Congress 2018 highlights from ERS Assembly 3 “Basic and Translational Science.” Marko Z. Nikolic, Eva M. Garrido-Martin, Flavia R. Greiffo, Aurélie Fabre, Irene H. Heijink, Agnes Boots, Catherine M. Greene, Pieter S. Hiemstra, Sabine Bartel ERJ Open Res, 5 (2) 00194-2018; 10.1183/23120541.00194-2018
Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity! Sebastiano Emanuele Torrisi, Brett Ley, Michael Kreuter, Marlies Wijsenbeek, Eric Vittinghoff, Harold R. Collard, Carlo Vancheri Eur Respir J, 53 (5) 1900615; 10.1183/13993003.00615-2019
Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity! Stéphane Jouneau, Mathieu Lederlin, Laurent Vernhet, Ronan Thibault Eur Respir J, 53 (5) 1900418; 10.1183/13993003.00418-2019
Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort Iain Stewart, Tricia McKeever, Rebecca Braybrooke, Eunice Oballa, Juliet K. Simpson, Toby M. Maher, Richard P. Marshall, Pauline T. Lukey, William A. Fahy, Gisli Jenkins, Gauri Saini Eur Respir J, 53 (5) 1801925; 10.1183/13993003.01925-2018
Long-term evaluation of home-based pulmonary rehabilitation in patients with fibrotic idiopathic interstitial pneumonias Benoit Wallaert, Louise Duthoit, Elodie Drumez, Hélène Behal, Lidwine Wemeau, Cécile Chenivesse, Jean-Marie Grosbois ERJ Open Res, 5 (2) 00045-2019; 10.1183/23120541.00045-2019
Incidence of autoimmune pulmonary alveolar proteinosis estimated using Poisson distribution Nobutaka Kitamura, Shinya Ohkouchi, Ryushi Tazawa, Haruyuki Ishii, Toshinori Takada, Takuro Sakagami, Takahiro Tanaka, Koh Nakata ERJ Open Res, 5 (1) 00190-2018; 10.1183/23120541.00190-2018
Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort Foteini Malli, Despoina Papakosta, Katerina Antoniou, Maria Dimadi, Vlassis Polychronopoulos, Katerina Malagari, Anastasia Oikonomou, Demosthenes E. Bouros, Zoe Daniil ERJ Open Res, 5 (1) 00014-2018; 10.1183/23120541.00014-2018
Pulmonary physiology is poorly associated with radiological extent of disease in systemic sclerosis-associated interstitial lung disease Amrit Jhajj, Harinder Pal Gill, Cameron J. Hague, Darra Murphy, Brett Elicker, Jeanette Soon, Nada Sulaiman, Daniela Castillo-Saldana, Pearce G. Wilcox, James Dunne, Joyce S. Lee, Paul J. Wolters, Brett Ley, Kirk D. Jones, Julie Morisset, Christopher J. Ryerson Eur Respir J, 53 (5) 1802182; 10.1183/13993003.02182-2018
Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials Vincent Cottin, Arata Azuma, Ganesh Raghu, Wibke Stansen, Susanne Stowasser, Rozsa Schlenker-Herceg, Martin Kolb Eur Respir J, 53 (4) 1801655; 10.1183/13993003.01655-2018
Of the need to reconcile discrepancies between two different reference equations for combined single-breath D_LNO–D_LCO in systemic sclerosis Thomas Radtke, Thông Hua-Huy, Holger Dressel, Anh Tuan Dinh-Xuan Eur Respir J, 53 (4) 1802109; 10.1183/13993003.02109-2018
Telomere length and genetic variant associations with interstitial lung disease progression and survival Chad A. Newton, Justin M. Oldham, Brett Ley, Vikram Anand, Ayodeji Adegunsoye, Gabrielle Liu, Kiran Batra, Jose Torrealba, Julia Kozlitina, Craig Glazer, Mary E. Strek, Paul J. Wolters, Imre Noth, Christine Kim Garcia Eur Respir J, 53 (4) 1801641; 10.1183/13993003.01641-2018
Predicting respiratory failure in amyotrophic lateral sclerosis: recruiting a few good pulmonologists Noah Lechtzin Eur Respir J, 53 (4) 1900360; 10.1183/13993003.00360-2019
Pulmonary fibrosis: “idiopathic” is not “cryptogenic” Athol U. Wells, Kevin K. Brown, Kevin R. Flaherty, Martin Kolb, Victor J. Thannickal Eur Respir J, 53 (3) 1900400; 10.1183/13993003.00400-2019
Pulmonary fibrosis: “idiopathic” is not “cryptogenic” Vincent Cottin Eur Respir J, 53 (3) 1802314; 10.1183/13993003.02314-2018
Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis Nasreen Khalil, Helene Manganas, Christopher J. Ryerson, Shane Shapera, Andre M. Cantin, Paul Hernandez, Eric E. Turcotte, Joseph M. Parker, John E. Moran, Gary R. Albert, Renata Sawtell, Aline Hagerimana, Pierre Laurin, Lyne Gagnon, Frank Cesari, Martin Kolb Eur Respir J, 53 (3) 1800663; 10.1183/13993003.00663-2018
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis Pauline T. Lukey, Stephen A. Harrison, Shuying Yang, Yim Man, Beverley F. Holman, Alaleh Rashidnasab, Gabrielle Azzopardi, Michael Grayer, Juliet K. Simpson, Philippe Bareille, Lyn Paul, Hannah V. Woodcock, Richard Toshner, Peter Saunders, Philip L. Molyneaux, Kris Thielemans, Frederick J. Wilson, Paul F. Mercer, Rachel C. Chambers, Ashley M. Groves, William A. Fahy, Richard P. Marshall, Toby M. Maher Eur Respir J, 53 (3) 1801992; 10.1183/13993003.01992-2018
Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies Paul J. Wolters, Vincent Cottin Eur Respir J, 53 (3) 1900283; 10.1183/13993003.00283-2019
Interstitial lung disease David N. O'Dwyer, Bethany B. Moore, Philip L. Molyneaux Eur Respir Monogr 2019; 83: 173-187
Talk from London Hub – Circulating biomarkers in idiopathic pulmonary fibrosis Gisli Jenkins (UK)
Talk from Warsaw – Tailoring drug therapy in idiopathic pulmonary fibrosis Wim Wuyts (BL)
Lung transplantation Hauke Winter (Heidelberg, Germany)
Familial ILDs Maria Molina Molina (Hospitalet de Llobregat (Barcelona), Spain)
Comorbidities in ILDs Michael Kreuter (Heidelberg, Germany)
Future treatment approaches in ILDs Athol Wells (London, United Kingdom)
Hot topics in ILDs, clinical year in review Toby Maher (St. Albans (Hertfordshire), United Kingdom)
Pathogenesis of ILDs, basic research year in review Maria Molina Molina (Hospitalet de Llobregat (Barcelona), Spain)
Hypersensitivity pneumonitis Martina Vasakova (Praha 4, Czech Republic)
Sarcoidosis Marlies S. Wijsenbeek (Rotterdam, Netherlands)
Unclassifiable ILD Vincent Cottin (Lyon, France)
Pulmonary vasculitis Vincent Cottin (Lyon, France)
Connective tissue disease-associated lung disease Michael Kreuter (Heidelberg, Germany)
Paediatric ILDs Ernst Eber (Graz, Austria)
ILD quiz Michael Kreuter (Heidelberg, Germany), Claus Peter Heussel (Heidelberg, Germany), Venerino Poletti (Forlì, Italy),
Occupational and drug-induced ILDs Bruno Crestani (Paris, France)
Combined fibrosis and emphysema syndrome Vincent Cottin (Lyon, France)
Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias) Bruno Crestani (Paris, France)
Non - IPF Idiopathic Interstitial Pneumonia (IIPs) Athol Wells (London, United Kingdom)
Idiopathic Pulmonary Fibrosis (IPF) Toby Maher (St. Albans (Hertfordshire), United Kingdom)
Can we diagnose ILD ? - Yes, we can! Interactive cases Michael Kreuter (Heidelberg, Germany), Venerino Poletti (Forlì, Italy), Claus Peter Heussel (Heidelberg, Germany)
Bronchoschopic and surgical diagnostic procedures in ILDs with live transmission from the operating room for transbronchial cry biopsies Venerino Poletti (Forlì, Italy)
Pathology of ILDs Venerino Poletti (Forlì, Italy)
Radiologic evaluation of ILDs Claus Peter Heussel (Heidelberg, Germany)
Clinical diagnosis, monitoring and biomarkers in ILDs Michael Kreuter (Heidelberg, Germany)
Transfer coefficient of the lung for carbon monoxide and the accessible alveolar volume: clinically useful if used wisely J. Alberto Neder, Mathieu Marillier, Anne-Catherine Bernard, Denis E. O'Donnell Breathe, 15 (1) 69; 10.1183/20734735.0345-2018
Research highlights from the 2018 ERS International Congress: interstitial lung diseases Tiago M. Alfaro, Catharina C. Moor, Veronica Alfieri, Florence Jeny, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti ERJ Open Res, 5 (1) 00215-2018; 10.1183/23120541.00215-2018
Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study Giacomo Sgalla, Anna Rita Larici, Nicola Sverzellati, Brian Bartholmai, Simon L.F. Walsh, Dragana Nikolic, Anna Barney, Sophie Fletcher, Mark Jones, Donna D Davies, Luca Richeldi Eur Respir J, 53 (3) 1802093; 10.1183/13993003.02093-2018
The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Sebastiano Emanuele Torrisi, Brett Ley, Michael Kreuter, Marlies Wijsenbeek, Eric Vittinghoff, Harold R. Collard, Carlo Vancheri Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018
The impact of the new Global Lung Function Initiative T_LCO reference values on trial inclusion for patients with idiopathic pulmonary fibrosis Monique Wapenaar, Jelle R. Miedema, Catharina J. Lammering, Frans W. Mertens, Marlies S. Wijsenbeek Eur Respir J, 53 (2) 1801895; 10.1183/13993003.01895-2018
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name? Athol U. Wells, Kevin K. Brown, Kevin R. Flaherty, Martin Kolb, Victor J. Thannickal Eur Respir J, 53 (2) 1801939; 10.1183/13993003.01939-2018
Idiopathic interstitial pneumonia or idiopathic interstitial pneumonitis: what's in a name? Lykourgos Kolilekas, Ulrich Costabel, Argyris Tzouvelekis, Vassilios Tzilas, Demosthenes Bouros Eur Respir J, 53 (2) 1800994; 10.1183/13993003.00994-2018
Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors Coralynn Sack, Ganesh Raghu Eur Respir J, 53 (2) 1801699; 10.1183/13993003.01699-2018